Journal of Applied Physiology
Vol. 83, No. 1,
pp. 297-311,
July 1997
SYSTEMIC CIRCULATION AND FLUID BALANCE
MODELING IN PHYSIOLOGY
A simplified strong ion model for acid-base equilibria: application
to horse plasma
Peter D.
Constable
College of Veterinary Medicine, University of Illinois at
Urbana-Champaign, Urbana, Illinois 61801
ABSTRACT
INTRODUCTION
HENDERSON-HASSELBALCH EQUATION
STRONG ION MODEL
MATERIALS AND METHODS
RESULTS
DISCUSSION
APPENDIX
FOOTNOTES
REFERENCES
ABSTRACT
Constable, Peter D. A simplified strong ion model for
acid-base equilibria: application to horse plasma. J. Appl. Physiol. 83(1): 297-311, 1997.
The
Henderson-Hasselbalch equation and Stewart's strong ion model are
currently used to describe mammalian acid-base equilibria. Anomalies
exist when the Henderson-Hasselbalch equation is applied to plasma,
whereas the strong ion model does not provide a practical method for
determining the total plasma concentration of nonvolatile weak acids
([Atot]) and the
effective dissociation constant for plasma weak acids
(Ka). A
simplified strong ion model, which was developed from the assumption
that plasma ions act as strong ions, volatile buffer ions
(HCO
3), or nonvolatile buffer ions,
indicates that plasma pH is determined by five independent variables:
PCO2, strong ion difference, concentration of individual nonvolatile plasma buffers (albumin, globulin, and phosphate), ionic strength, and temperature. The simplified strong ion model conveys on a fundamental level the mechanism for change in acid-base status, explains many of the anomalies when the Henderson-Hasselbalch equation is applied to plasma,
is conceptually and algebraically simpler than Stewart's strong ion
model, and provides a practical in vitro method for determining
[Atot] and
Ka of plasma.
Application of the simplified strong ion model to
CO2-tonometered horse plasma
produced values for
[Atot] (15.0 ± 3.1 meq/l) and Ka
(2.22 ± 0.32 × 10
7 eq/l) that were
significantly different from the values commonly assumed for human
plasma ([Atot] = 20.0 meq/l, Ka = 3.0 × 10
7 eq/l).
Moreover, application of the experimentally determined values for
[Atot] and
Ka to published
data for the horse (known PCO2,
strong ion difference, and plasma protein concentration) predicted
plasma pH more accurately than the values for
[Atot] and
Ka commonly
assumed for human plasma. Species-specific values for
[Atot] and
Ka should be
experimentally determined when the simplified strong ion model (or
strong ion model) is used to describe acid-base equilibria.
acid-base balance; acidosis; alkalosis; alphastat; strong ion
difference
INTRODUCTION
TWO METHODS ARE CURRENTLY used clinically to describe
the physicochemical determinants of plasma pH in mammals: the
Henderson-Hasselbalch equation (20) and Stewart's strong ion model
(44-46). The purpose of this study is to briefly discuss the
strengths and weaknesses of the Henderson-Hasselbalch equation and
Stewart's strong ion model and to develop a simplified strong ion
model that is conceptually and algebraically simpler than Stewart's
strong ion model. The simplified strong ion model also explains many of
the anomalies observed when the Henderson-Hasselbalch equation is
applied to plasma.
HENDERSON-HASSELBALCH EQUATION
The traditional approach used to clinically describe mammalian
acid-base equilibria focuses on how
PCO2,
HCO
3 concentration
([HCO
3]), the negative
logarithm of the equilibrium constant
(pK
1), and the
solubility of CO2 in plasma
(SCO2) interact
to determine the plasma pH (35). This relationship is most commonly
expressed as the Henderson-Hasselbalch equation (20, 23, 31)
|
(1)
|
where
pK
1 is a collective
equilibrium constant for the reaction
|
(2)
|
The Henderson-Hasselbalch equation has proven to be invaluable in
aiding our understanding of mammalian acid-base physiology and is
routinely and widely used in the clinical management of acid-base
abnormalities in humans and animals (2, 7, 25, 40). However, it was
evident as early as 1922 that factors other than
PCO2,
[HCO
3],
pK
1, and
SCO2 influence
plasma pH (52).
SCO2 varies
with ionic strength, temperature, and protein concentration, and
accurate values are available for mammalian plasma (3). Determination
of accurate pK
1
values for plasma has been more problematic, inasmuch as the
experimental value for
pK
1 in plasma
(called the apparent dissociation constant) differs marginally from the
value obtained in aqueous, nonplasma solutions (1, 8, 19, 21, 27, 29,
31, 34, 38, 39). Moreover, like all equilibrium constants based on
molalities, the value for
pK
1 is dependent on
the ionic strength (21) and temperature (8). A number of studies have
demonstrated that the apparent value for
pK
1 in plasma is
also influenced by pH (1, 27, 29, 34, 38), protein concentration (27,
29), and Na+ concentration (22),
leading to routine adjustment of the
pK
1 for plasma by
nomograms (40, 41), tables (3, 27, 34), and polynomial equations (19,
22). The mechanistic basis for these adjustments is unknown.
Numerous experiments have demonstrated that the in vitro log
PCO2-pH equilibration curve for
plasma is well approximated by a straight line over the normal
physiological range (2, 40, 52) (Fig. 1).
The Henderson-Hasselbalch equation partially explains this finding,
inasmuch as rearrangement of Eq. 1
provides
|
(3)
|
indicating
that the log PCO2-pH relationship is
linear with an intercept value of
log([HCO
3]/K
1SCO2). Experimental studies have also found that the linear relationship between log PCO2 and pH is displaced
by changes in the protein concentration (2) or the addition of
Na+ or
Cl
(2, 39) (Fig. 1),
suggesting that the intercept value has changed. Other studies have
found that the in vitro relationship between log
PCO2 and pH becomes nonlinear in
markedly acidic plasma (40), suggesting that the intercept value is pH dependent and is nonlinear during in vivo
CO2 equilibration studies (6, 10)
(Fig. 1). The Henderson-Hasselbalch equation provides no explanation
for these phenomena.
Fig. 1.
Line plots of linear in vitro (
,
,
,
) and
curvilinear in vivo (dots) log
PCO2-pH realtionship for human
plasma.
, Plasma with a protein concentration of 7 g/dl (normal
[Atot] and
[SID+]);
, plasma
with a protein concentration of 13 g/dl (increased [Atot]) (data from
Ref. 2);
, plasma with a decrease in
[SID+] of 25 meq/l;
, plasma with an increase in
[SID+] of 50 meq/l
(data from Ref. 2). Dots, curvilinear in vivo log
PCO2-pH relationship (data from Refs.
6 and 10). [Atot],
total plasma concentration of nonvolatile weak acid;
[SID+], strong ion
difference.
[View Larger Version of this Image (22K GIF file)]
Because the Henderson-Hasselbalch equation does not satisfactorily
explain why the apparent value of
pK1 in plasma
depends on pH, protein concentration, and
Na+ concentration and why a
nonlinear relationship exists between log
PCO2 and pH in vitro over a wide
range of pH and in vivo during CO2
equilibration studies, the approach can only be accurately applied to
mammalian plasma at approximately normal pH, protein concentration, and
Na+ concentration. Moreover, the
empiric nature of the adjustments to the value of
K
1 in plasma
indicates that the Henderson-Hasselbalch equation is more descriptive
than mechanistic.
STRONG ION MODEL
Dissatisfaction with the Henderson-Hasselbalch approach prompted Singer
and Hastings (41) to propose in 1948 that plasma pH was determined by
two independent factors, PCO2 and net
strong ion charge, equivalent to the strong ion difference ([SID+]) (41). Stewart
(44-46) later proposed that a third variable, the total plasma
concentration of nonvolatile weak acids
([Atot]), also exerted
an independent effect on plasma pH. By combining equations for
conservation of charge, conservation of mass, and dissociation
equilibrium reactions, Stewart developed a polynomial equation relating
the plasma H+ concentration
[H+] to three
independent variables (PCO2,
[SID+], and
[Atot]) and five
"constants"
(Ka,
K
w,
K
1, K3, and
SCO2) (45,
46)
|
(4)
|
where
Ka is the
effective equilibrium dissociation constant for plasma weak acids,
K
w is the ion
product of water,
K
1 is the apparent
equilibrium constant for the Henderson-Hasselbalch equation,
SCO2 is the
solubility of CO2 in plasma, and
K3 is the
apparent equilibrium dissociation constant for
HCO
3.
Although the strong ion model offers a unique insight into the
pathophysiology of acid-base derangements in mammals and is mechanistic
(11, 25), Stewart's approach has not been widely accepted, because it
does not provide a practical method for determining [Atot] and
Ka (7). The most
commonly used value for
[Atot] is 20 meq/l
{calculated from the net protein charge, where
[Atot] (in meq/l) = 2.4 × [total protein] = 8.3 g/dl, where [total
protein] is total protein concentration} (25, 50);
however, a recent study suggested that the correct value for
[Atot] in human plasma is ~14 meq/l {calculated as
[Atot] (meq/l) = 1.7 × [total protein] = 7 g/dl + 1.8 × phosphate
concentration = 1 mmol/l} (13). A number of different values for
Ka (2 × 10
7, 3 × 10
7, 4 × 10
7, and 4 × 10
8 eq/l) have been
suggested (44-46), with 3 × 10
7 eq/l being the most
commonly used value (11, 15, 25, 26, 30, 53). It is unclear which
values for [Atot] and
Ka should be used
when the strong ion model is applied to nonhuman plasma, inasmuch as it
is likely that species differences in values for [Atot] and
Ka exist (15).
From an experimental viewpoint, the strong ion model is considered by
some authors to offer no significant improvement over the conventional
Henderson-Hasselbalch equation (7, 22). However, from a clinical
viewpoint, the strong ion model is invaluable, in that it offers a
novel insight into the pathophysiology of mixed acid-base disorders
(11, 15, 25). In particular, the effects of hypoproteinemia and
hyperproteinemia on acid-base status (35) can be satisfactorily
explained only by the strong ion model.
In summary, deficiencies exist in present methods to describe mammalian
acid-base equilibria. Accordingly, Stewart's strong ion model was
conceptually and algebraically reduced in the hope that a simpler model
would 1) explain the apparent
dependence of plasma
pK
1 on
pH, protein concentration, and Na+ concentration;
2) explain why the log
PCO2-pH relationship for plasma is
displaced by changes in plasma protein,
Na+, and
Cl
concentration and is
nonlinear in vivo and in markedly acidic plasma;
3) provide a practical method for
experimentally determining values for
[Atot] (in meq/l) and
Ka (in eq/l) in
plasma; and 4) provide an acid-base
model that unites the Henderson-Hasselbalch equation and strong ion
model.
MATERIALS AND METHODS
Model development.
The simplified model reduces the chemical reactions in plasma to that
of simple ions in solution. This assumption can be made because the
major plasma cations (Na+,
K+,
Ca2+, and
Mg2+) and anions
(Cl
,
HCO
3, protein,
lactate
, and
sulfate2
) bind each other
in a salt-type manner (9, 49, 52). Plasma ions that enter into
oxidation-reduction reactions, complex ion interactions, and
precipitation reactions are not categorized as simple ions (9, 49).
Plasma ions such as Cu2+,
Fe2+,
Fe3+,
Zn2+,
Co2+, and
Mn2+, which are not simple ions
(49), are assumed to be quantitatively unimportant in determining
plasma pH, primarily because their plasma concentrations are low.
Simple ions in plasma can be differentiated into two types: nonbuffer
ions (strong ions or strong electrolytes) and buffer ions (Table
1). Strong ions are considered to be fully
dissociated at physiological pH (4) and therefore exert no buffering
effect. Strong ions do, however, exert an electrical effect, because
the sum of completely dissociated cations does not equal the sum of completely dissociated anions (45). Stewart (44-46) termed this difference the strong ion difference (SID), which is always positive in
plasma. Because strong ions do not participate in chemical reactions in
plasma at physiological pH, for practical purposes the strong ions can
be regarded as a collective unit of charge, the
SID+. The concentration of this
charge in plasma is expressed as
[SID+] (in meq/l).
|
Table 1.
Categorization of simple ions in equine plasma and approximate values
for their normal concentration
|
Nonbuffer Ions (Strong Ions)
|
Buffer Ions
|
| Cation |
Concn, meq/l |
Anion
|
Concn, meq/l |
Volatile anion |
Concn, meq/l
|
Nonvolatile anion |
Concn, meq/l |
|
| Na |
140 |
Cl
|
105 |
HCO3 |
27.2 |
Protein |
12.0 |
| K |
4
|
Lactate |
1.0 |
|
|
Phosphate |
2.7 |
| Ca |
5
|
Sulfate |
1.0 |
|
|
Citrate |
0.3 |
| Mg |
2
|
Nonesterified fatty acid |
0.6 |
| NH4 |
0.1
|
Urate |
0.5 |
|
|
Succinate |
0.5 |
|
|
Ketone
bodies |
0.2 |
|
|
Pyruvate |
0.1 |
|
|
|
|
|
|
Values were derived from unpublished data and Refs. 17, 18, and
49. Ionic contribution of amino acids is ignored in this scheme,
because at normal pH the sum of the positive and negative free amino
acid charge approximates zero.
|
|
In contrast to strong ions, buffer ions are derived from plasma weak
acids and bases that are not fully dissociated at physiological pH. The
Bronsted-Lowry theory defines an acid as any substance that can donate
protons. The dissociation reaction for a weak acid-conjugate base pair,
HA and A
, is
|
(5)
|
and
at equilibrium,
Ka can be
calculated from the law of mass action (23)
|
(6)
|
where
aH+
represents H+ activity and
[HA] and
[A
] represent
the plasma concentrations of weak acid and conjugate base,
respectively. The value for
Ka will depend on
temperature and ionic strength, inasmuch as it is being defined in
terms of the activity of H+ and
[A
] and
[HA] (molarity). For a weak acid to act as an effective buffer, its pKa
must lie within the range of pH ±1.5 (9, 22, 32). On this basis,
substances in plasma that act as weak acids at physiological pH have a
pKa between 5.9 and 8.9 (Table 2). Ions derived from weak
acids with a pKa
outside this range are classified as nonbuffer ions (strong ions;
Tables 1 and 2).
|
Table 2.
Approximate pKa values for acids that produce nonbuffer
ions (strong ions) or buffer ions in plasma at physiological pH
|
| Ion |
Acid |
pKa
|
|
| Nonbuffer ions (strong
ions) |
| Sulfate |
HSO 4
|
1.3-2.0 |
H2PO 4
|
Phosphoric acid |
1.9-2.2 |
| Pyruvate |
Pyruvic acid
|
2.3-2.5 |
| Acetoacetate |
Acetoacetic acid |
3.6
|
| Lactate |
Lactic acid |
3.7-3.9 |
| Carboxyl protein group
|
R-COOH |
3.7-4.0 |
-OH butyrate |
-OH butyric acid
|
4.3 |
| Succinate |
Succinic acid |
5.2-5.6
|
| Urate |
Uric acid |
5.6
|
| NH+4
|
NH+4 |
9.2-9.3
|
CO2 3
|
HCO 3 |
9.8-10.3 |
-Amino
protein group |
R-NH+3 |
9.8-10.6
|
| Guanidine protein group
|
R-NH+2 |
11.9-13.3
|
| Buffer ions |
| Volatile
|
| Bicarbonate |
Carbonic acid |
6.0-6.4 |
| Nonvolatile
|
| Citrate |
Citric acid |
5.7-6.4 |
| Imidazole protein
group |
ImH+ |
6.4-7.0 |
-Amino protein
group |
RNH+3COO
|
7.4-7.9 |
HPO2 4
|
H2PO 4
|
6.7 |
|
|
Values were obtained from Refs. 9 and 42. Range of values reflects
value for pKa at ionic strengths of 0-0.5
(ionic strength of plasma = 0.16).
|
|
Conceptually, the buffer ions can be subdivided into volatile buffer
ion (bicarbonate) and nonvolatile buffer ions (nonbicarbonate). Bicarbonate is considered separately, because this buffer system is an
open system in arterial plasma (25); rapid changes in PCO2 and, hence, arterial plasma
bicarbonate concentration can be readily induced through alterations in
respiratory activity (25). In contrast, the nonbicarbonate buffer
system is a closed system containing a relatively fixed quantity of
buffer. Another important physiological distinction between these two
buffer systems is that an open buffer system such as bicarbonate can be
effective beyond the limits of pH = pKa ± 1.5. Finally, it should be appreciated that bicarbonate is a homogeneous
buffer ion, whereas the nonvolatile buffer ion
(A
) represents a diverse
and heterogeneous group of plasma buffers consisting primarily of
dissociable imidazole and
-amino groups on plasma proteins with a
smaller contribution from phosphate-containing weak acids and citrate
(Tables 1 and 2). It should be emphasized that the heterogeneous group
of nonvolatile buffer ions is being treated as if it were a single
buffer with a classical sigmoidal titration curve. This modeling
assumption is validated later and is consistent with the alphastat
theory for acid-base regulation, which proposes that nonvolatile plasma
buffers can be modeled as a single imidazole group (32). The derivation
of Stewart's strong ion model requires the same modeling assumption.
On the basis of the information stated above, plasma contains three
types of charged entities: SID+,
HCO
3, and
A
. The requirement for
electroneutrality dictates that at all times [SID+] equals the sum
of [HCO
3] and nonvolatile
[A
], such that
|
(7)
|
Equation 7 obviously assumes that all ionized entities in plasma
can be classified as a strong ion
(SID+), a volatile buffer ion
(HCO
3), or a nonvolatile buffer ion
(A
). This assumption
forms the basis for the simplified strong ion model. The
electroneutrality equation is similar to that developed by Singer and
Hastings in 1948 (41) but differs from that developed by Stewart
(44-46), who preferred the following
|
(8)
|
where
[CO2
3] and
[OH
] are
CO2
3 and
OH
concentration,
respectively. In plasma,
[SID+],
[HCO
3], and
[A
] are present
in milliequivalents per liter, whereas
[CO2
3] exists in
microequivalents per liter and
[OH
] and
[H+] exist in
nanoequivalents per liter. Because of the large differences in the
magnitudes of the factors in Stewart's electroneutrality equation,
Eq. 8 does not appear to offer any
significant improvement over Eq. 7.
The simplified strong ion model therefore assumes that the ionic
charges carried by
[CO2
3],
[OH
], and
[H+] are
quantitatively unimportant. This assumption is validated later.
Another assumption in the simplified strong ion model (and Stewart's
strong ion model) is that HA and
A
do not take part in
plasma reactions that result in the net destruction or creation of HA
or A
. This is because when
HA dissociates, it ceases to be HA (therefore reducing the plasma
[HA]) and becomes
A
(therefore increasing the
plasma [A
]).
The sum of [HA] and
[A
] (called
Atot) therefore remains constant
through conservation of mass (45). This is expressed as a mass balance
statement
|
(9)
|
The
units of [HA] and
[A
] are
millimoles per liter and not milliequivalents per liter as used by
Stewart (44-46), because mass, not charge, is conserved. In plasma
under physiological conditions, HA consists of four dissociable groups:
imidazole,
-amino, phosphate, and citric acid (Table 2). Human
plasma contains
9.51 mmol/l of dissociable imidazole groups and
2.38 mmol/l of dissociable
-amino groups, because
1) there are 16 dissociable imidazole groups and 4 dissociable
-amino groups per albumin molecule (Table 3) (47),
2) there is 0.59 mmol of albumin per liter of plasma on the basis of a plasma albumin concentration of 4.1 g/dl and a molecular weight for albumin of 69,000 (47), and
3) the number of dissociable
imidazole and
-amino groups in plasma is greater than or equal to
that for albumin. Human plasma also contains 1.29 mmol/l of dissociable
phosphate groups, on the basis of a plasma phosphate concentration of 4 mg/dl, and <0.6 mmol/l of dissociable citric acid.
[Atot] for human
plasma is therefore
13.8 mmol/l, inasmuch as
[Atot]plasma = [Atot]imidazole + [Atot]
-amino + [Atot]phosphate + [Atot]citric
acid. To facilitate further calculations, it is
desirable to express
[Atot] in terms of
milliequivalents per liter instead of millimoles per liter. This can be
accomplished by using the equilibrium constant for acid dissociation
and attributing a valence to [HA] and
[A
] for the
four dissociable groups (see APPENDIX
A). The derivation suggests that the value of
[Atot] for human
plasma, when expressed in terms of milliequivalents per liter, varies with plasma pH and is ~18.0 meq/l at physiological pH
(APPENDIX A). A more accurate
estimate for [Atot],
in terms of milliequivalents per liter, cannot be calculated by this
method, inasmuch as detailed information for protein composition is not
available for plasma proteins other than albumin.
|
Table 3.
Approximate intrinsic pKa values and number of dissociable
groups on plasma albumin
|
| Group |
pKa
|
Human Serum Albumin
|
Bovine
Serum Albumin
|
| Number |
Attributed charge, eq |
Number
|
Attributed charge, eq |
|
| Strong (dissociated)
ions |
| Carboxyl |
3.7-4.0 |
106 |
106 |
100
|
100 |
-Amino |
9.8-10.6 |
56 |
+56 |
57
|
+57 |
| Guanidine |
11.9-13.3 |
24 |
+24 |
22
|
+22 |
| Dissociable ions |
| Imidazole |
6.4-7.0 |
16
|
+2.7 |
16 |
+2.7 |
-Amino |
7.4-7.9 |
4
|
1.3 |
1 |
0.3 |
|
|
Values were derived from Refs. 47 and 48.
|
|
We now have enough information to express pH in terms of the plasma
constituents. Substituting [HA] in Eq. 9 into Eq. 6 produces
|
(10)
|
rearrangement
produces
|
(11)
|
Substituting
for [A
] from
Eq. 7 and taking the reciprocal of
both sides produces
|
(12)
|
Taking
the logarithm of both sides provides
|
(13)
|
and
because pH =
log
aH+
and pKa =
log Ka
|
(14)
|
Equation 14 provides a simple
expression relating plasma pH to four variables:
pKa,
[Atot],
[SID+], and
[HCO
3]. Unfortunately, not
all variables in Eq. 14 are
independent, inasmuch as
[HCO
3] is dependent on
another variable, PCO2 (45). Because it is valuable to express pH in terms of independent variables (44-46), Eq. 14 was algebraically
manipulated (see APPENDIX B) to
provide an equation relating pH to Stewart's three independent variables (PCO2,
[SID+], and
[Atot]), the solution
being
|
(15)
|
Equation 15 indicates that plasma pH is determined by three
independent variables (PCO2,
[SID+], and
[Atot]) and three
"variable constants"
(Ka,
K
1, and
SCO2). The
latter three factors are considered variable constants, because
Ka and
K
1, like all
apparent equilibrium constants, are affected by temperature and ionic
strength and SCO2 is
affected by temperature, ionic strength, and protein concentration (3).
Under the condition PCO2 = 0, at which time [HCO
3] = 0 and [SID+] = [A
] by virtue
of Eq. 7, Eq. 15 reduces to the law of
mass action for a weak acid (Eq. 6). Under the condition
[Atot] = 0, at which time
[A
] = 0 and
[SID+] = [HCO
3] by virtue of
Eq. 7, Eq. 15 reduces to the
Henderson-Hasselbalch equation (Eq. 1). The latter may be more readily appreciated if
Eq. 14 is rearranged in terms of [HCO
3] and substituted
into Eq. 1
|
(16)
|
In contrast to the individual conditions
PCO2 = 0 or
[Atot] = 0, Eqs. 15 and 16 indicate that the mathematical
condition [SID+] = 0 cannot exist, inasmuch as in this case there is no solution for plasma
pH, because the logarithm of a number
0 does not exist. However,
because of the law of electroneutrality and the fact that volatile and
nonvolatile plasma buffers are negatively charged, as
[SID+] approaches
zero, [HCO
3] or
[A
] must also
approach zero but be closer to zero by virtue of Eq. 7. This means that the simplified strong ion model
reduces to the equilibrium reaction for plasma weak acids or the
Henderson-Hasselbalch equation before the condition
[SID+] = 0 exists. In
summary, the simplified strong ion model reduces to appropriately
simpler models under the conditions
PCO2 = 0 or
[Atot] = 0, whereas Stewart's strong ion model (Eq. 4) is not appreciably simplified under these
conditions.
As stated previously, the electroneutrality equation used to derive the
new acid-base model differs from that used by Stewart. Because his
electroneutrality equation contains six unknowns, Stewart's approach
requires six simultaneous equations to solve for
[H+], specifically
Eqs. 1, 6, 8, 9, and two additional
equilibrium equations (45, 46)
|
(17)
|
|
(18)
|
where
K
w is the ion
product of water and
K3 represents the
equilibrium dissociation constant for bicarbonate. Stewart (46) stated
that "nothing less than the whole set of six equations is
sufficient" to explain pH behavior. A solution for
Eq. 4 can also be generated through
algebraic manipulation and simplification, as detailed in
APPENDIX C. The solution demonstrates
that Stewart's fourth-order polynomial equation (Eq. 4), which is derived from six equations and eight
factors, can be algebraically simplified to Eq. 14, which was derived from four equations and six
factors. In other words, Eq. 15,
derived from the simplified strong ion model, produces values for
plasma pH identical to those produced by Eq. 4, derived from Stewart's strong ion model, but from
fewer variables.
A comparison between the plasma pH predicted by Stewart's polynomial
equation (Eq. 4) and the simplified
strong ion model (Eq. 15) for
solutions of widely varying PCO2,
[SID+], and
[Atot] confirms that
the algebraic reduction detailed in APPENDIX
C is valid, inasmuch as the equations produce identical
results, allowing for rounding error (Table
4). The finding also confirms the
assumption made earlier that the simpler electroneutrality equation is
valid. The conclusion that leads directly from this observation is that
the dissociation equilibrium between
HCO
3 and
CO2
3 and the dissociation
equilibrium of water do not play a quantitatively important role in the
physicochemical determination of plasma pH.
|
Table 4.
Comparison of plasma pH predicted by Stewart's strong ion model (Eq. 4) and that predicted by the simplified strong ion model (Eq. 15) for
equine plasma from known PCO2,
[SID+], and [Atot]
|
| PCO2, Torr
|
[SID+], meq/l
|
[Atot], meq/l |
pH
Predicted by
|
| Stewart's strong ion model (Eq. 4)
|
Simplified strong ion model (Eq. 15)
|
|
| Normal values
|
| 44 |
40 |
15 |
7.432 |
7.432
|
| 50% change in
PCO2 |
| 22 |
40 |
15 |
7.716
|
7.718 |
| 66 |
40 |
15 |
7.268 |
7.268
|
| 50% change in
[SID+] |
| 44 |
20 |
15 |
6.987
|
6.988 |
| 44 |
60 |
15 |
7.663 |
7.664
|
| 50% change in
[Atot] |
| 44 |
40 |
7.5 |
7.521
|
7.522 |
| 44 |
40 |
22.5 |
7.329 |
7.329 |
|
Values for the other variables in each model at 37°C were as
follows: Ka = 2.22 × 10 7 eq/l,
Kc = K 1SCO2 = 2.281 × 10 11
eq · l 1 · Torr 1,
K w = 4.4 × 10 14
eq2/l2, K3 = 6.0 × 10 11 eq/l. [SID+], strong ion
difference; [Atot], total plasma concentration of volatile weak acids.
|
|
Clinical application of the new model.
Some limitations exist in the practical clinical application of the
simplified strong ion model, primarily because of difficulties in
obtaining accurate values for
[SID+],
[Atot], and
Ka. Similar
difficulties exist with Stewart's strong ion model (30). The factors
[SID+],
[Atot], and
Ka cannot be
easily measured in plasma, and their values must therefore be
estimated, assumed, or derived from the plasma constituents.
Determination of
[SID+] requires
identification and measurement of all strong ions in plasma (Tables 1
and 2). This can be an arduous and difficult task, since unidentified
strong ions may be present (11, 28). Despite these shortcomings, a
clinically practical estimate of
[SID+] can be obtained
by determining the plasma concentration of at least four strong ions
(Na+,
K+,
Cl
, and
lactate
), whereby
[SID+] = [Na+] + [K+]
[Cl
]
[lactate
],
where [Na+],
[K+],
[Cl
], and
[lactate
] are
Na+,
K+,
Cl
, and
lactate
concentrations (14,
15, 43, 53). Other investigators have employed different equations to
estimate [SID+], e.g.,
[SID+] = [Na+] + [K+]
[Cl
] (12),
[SID+] = [Na+] + [K+] + [Ca2+]
[Cl
]
[lactate
] (26,
30), [SID+] = [Na+] + [K+] + [Ca2+] + [Mg2+]
[Cl
] (11, 12),
[SID+] = [Na+] + [K+] + [Ca2+] + [Mg2+]
[Cl
]
1.5 (13), and [SID+] = [Na+] + [K+] + [Mg2+]
[Cl
]
[citrate
] (35),
where [Ca2+],
[Mg2+], and
[citrate
] are
concentrations of Ca2+,
Mg2+, and
citrate
. All these
different mathematical approaches provide an estimate of
[SID+] instead of the
exact value, because 1) each method
assumes that the sum of the unmeasured strong cations approximates the
sum of the unmeasured strong anions,
2) unmeasured strong ions may become
quantitatively important in specific pathological states (28),
3) each method does not directly
incorporate the effect of sulfate, which is a strong anion with an
approximate plasma concentration of 1 meq/l (30), and
4) each individual measurement is
subject to error, thereby leading to a larger cumulative error in
[SID+].
An estimate for [Atot]
in milliequivalents per liter can be obtained for normal human plasma
by multiplying total protein concentration (in g/dl) by 2.4 (25, 50) or
the albumin concentration (in g/dl) by 4.0 (35), inasmuch as
[Atot] essentially
represents the ionic equivalent of plasma proteins and phosphate. This
method may be inaccurate in human plasma (13) or when applied to
nonhuman plasma, inasmuch as the protein charge, albumin-to-globulin
ratio, and inorganic phosphate concentration vary among species (12, 13, 15, 30, 49, 50) (APPENDIX A).
Instead of estimating general values for
[Atot] and
Ka,
species-specific values can be experimentally determined by nonlinear
regression using Eq. 15 of the
simplified strong ion model and known values for pH,
PCO2, and
[SID+] obtained from
plasma equilibrated with different
PCO2. This requires measurement of pH
and PCO2, estimation of
[SID+] from
[Na+],
[K+],
[Cl
], and
[lactate
], and
measurement of the predominant volatile buffers in plasma (total
protein, albumin, globulin, and phosphate) to express
[Atot] in a meaningful
manner. Nonlinear regression can also be applied to Stewart's strong
ion equation (Eq. 4) to solve for
[Atot] and Ka; however, this
approach may fail to provide a solution or produce unrealistic values
for [Atot] and
Ka, suggesting an
overspecified model or the presence of multicollinearity (16). An
alternative method for determining
Ka based on
computer modeling of ionizable groups has been used to predict
Ka for human
albumin (13); however, this procedure is laborious, requires detailed
knowledge of the structure and composition of albumin for each species,
and appears to produce an estimate for
Ka (0.5 × 10
7 eq/l) (13) of human
plasma that differs from that of imidazole (1.9 × 10
7 eq/l) (32).
Data acquisition for experimental determination of
[Atot] + Ka in equine
plasma.
Venous blood was collected anaerobically from six healthy adult horses
(3 females, 3 males) into tubes containing heparin sodium and
centrifuged, and the plasma was harvested. Plasma samples were
equilibrated at 37°C for 20 min with a water vapor-saturated gas
containing CO2 (range 6-70
Torr) by a tonometer (model IL237, Instrumentation Laboratory,
Lexington, MA). Various mixtures of two
CO2 gases (2%
CO2-17%
O2-81%
N2 and 10%
CO2-7%
O2-83%
N2) were used to provide a wide
range of PCO2. The pH and PCO2 of the tonometered plasma
samples were determined at 37°C by a pH/blood gas analyzer (model
238, Ciba Corning, Halstead, UK). Plasma concentrations of
Na+,
K+,
Cl
, albumin, total protein,
and phosphate were determined by automated methods (model 704 Automatic
Analyzer, Hitachi, Tokyo, Japan). Plasma
[lactate
] was
determined by spectrophotometric methods (Sigma Chemical, St. Louis,
MO). The [SID+] was
calculated as [SID+] = [Na+] + [K+]
[Cl
]
[lactate
], with
all values in milliequivalents per liter.
Nonlinear regression was applied using the simplified strong ion model
(Eq. 15) and known values for pH,
PCO2,
[SID+],
SCO2, and K
1 to
solve for [Atot] and
Ka. The value
used for SCO2 in plasma
at 37°C was 0.0307 Torr
1 (3). The value for
pK
1 at
37°C and an ionic strength of 0.16 (mammalian extracellular fluid)
was obtained from the sum of
pKs (6.038; Table
II, interpolated, Ref. 19) and the negative logarithm of the activity
coefficient of H+ (0.091) (31),
producing a value of 6.129. Nonlinear regression was also performed
using Stewart's electroneutrality equation (Eq. 8) in the following form:
PCO2 = {[H+]/(K
1SCO2 + K3K
1SCO2/[H+])} × ([SID+]
{Ka[Atot]/(Ka + [H+])} + [H+]
Kw/[H+]).
The values used for
K3 and
Kw were 6 × 10
11 eq/l and 4.4 × 10
14
eq2/l2,
respectively. Marquardt's expansion algorithm (PROC NLIN, SAS Institute) was used for the nonlinear regression procedure (16, 37) on
the basis of initial values for
[Atot] of 5-30
meq/l in 5 meq/l increments and for
Ka of 1-9 × 10
7 eq/l in 1 × 10
7 eq/l
increments.
Nonlinear regression (using the simplified strong ion model
Eq. 15) was also applied to
published values for pH, PCO2, and
[SID+] obtained from
CO2 equilibration of equine plasma
albumin, globulin, and serum protein solutions (50, 51). Inasmuch as
equilibration in these studies was accomplished at 38°C,
temperature-adjusted values for
SCO2 (0.0301 Torr
1) (3) and
pK
1 [6.1201;
obtained from the sum of
pKs (6.0300;
Table II, interpolated, Ref. 19) and the negative logarithm of the
activity coefficient of H+
(0.0901) (31)] were used. Calculated values for
[Atot] and Ka were expressed
as estimated means ± SE of the estimate.
Model validation.
The simplified strong ion model was validated by applying the mean
values for [Atot] and
Ka obtained by
the method described above to published blood- gas and serum
biochemical data derived from horses and ponies given endotoxin or
strong electrolyte solutions such as sodium bicarbonate, sodium
chloride, sodium lactate, and dilute hydrochloric acid (17, 18, 36).
The total protein concentration was estimated from the albumin
concentration, assuming that total protein concentration (g/dl) = 2.09 × albumin concentration (g/dl), in the studies (17, 18) where the
total protein concentration was not reported. The plasma lactate
concentration was calculated from the whole blood lactate
concentration, assuming a hematocrit of 42% and using the following
adjustment (24):
[lactate]plasma = [lactate]blood/(1
0.56 × hematocrit), where
[lactate]plasma and
[lactate]blood are
lactate concentrations in plasma and blood. The plasma lactate
concentration was assumed to have a constant value (1.2 meq/l) in the
experimental study (36) where it was not measured. The
[SID+] was calculated
as follows: [SID+] = [Na+] + [K+]
[Cl
]
[lactate
], with
all values in milliequivalents per liter. The values for pK
1 and
SCO2 were 6.129 and 0.0307 Torr
1,
respectively. Equation 15 was then
used to predict the plasma pH from the reported values for
PCO2,
[SID+], and total
protein concentration obtained during the experimental studies. The
calculated pH values were then compared with the measured pH values by
linear regression analysis for each data set, and the means ± SD
for the slope and intercept were determined.
RESULTS
Experimental determination of
[Atot] and
Ka.
Nonlinear regression using the simplified strong ion model
(Eq. 15) produced a value for horse
plasma [Atot] of
15.0 ± 3.1 (SD) meq/l and for horse plasma and a value
for Ka of
2.22 ± 0.32 × 10
7 eq/l (Table
5). The 95% confidence interval for
[Atot] and
Ka for horse
plasma did not contain the values commonly used for human plasma
([Atot] = 20 meq/l,
Ka = 3.0 × 10
7 eq/l).
|
Table 5.
[Atot] and Ka determined from nonlinear
regression of equine plasma equilibrated with different
PCO2
|
| Animal No. |
n |
pH
Range |
R2 |
Simplified
Strong Ion Model
|
Stewart's Strong Ion Model
|
| [Atot], meq/l |
Ka,
10 7 eq/l |
[Atot], meq/l
|
Ka, 10 7 eq/l
|
|
| Females |
| 1 |
7 |
7.34-8.29 |
0.99 |
16.5
|
2.64 |
NA |
NA |
| 2 |
10
|
7.28-7.95 |
0.96 |
13.3 |
2.11 |
NA
|
NA |
| 3 |
8 |
7.28-7.84 |
0.98 |
15.0
|
1.99 |
16.0 |
1.46 |
| Males |
| 1 |
8
|
7.30-7.93 |
0.98 |
15.3 |
1.95 |
15.1 |
2.23 |
| 2
|
7 |
7.40-7.81 |
0.98 |
19.7 |
1.99 |
20.7 |
1.44
|
| 3 |
11 |
7.32-7.86 |
0.94 |
10.4 |
2.61 |
9.0
|
0.06 |
|
|
n, No. of samples; NA, not available (values could not
be estimated).
|
|
When calculated solely from the total protein concentration,
[Atot] (in meq/l) = (2.24 ± 0.42) × [total protein] (in g/dl). Because this value assigns the
[Atot] contribution of
inorganic phosphate to total protein, this formula should be used only
in horse plasma with normal phosphate concentration. The direct
contributions of total protein and phosphate to
[Atot] were 12.3 and
2.7 meq/l, respectively, on the basis of a mean total protein
concentration of 6.7 g/dl, a mean phosphate concentration of 4.6 mg/dl,
and assignment of valences to phosphate as described in
APPENDIX A. A more complete formula
for estimating [Atot]
in horse plasma with a normal albumin-to-globulin ratio (0.90 ± 0.12) but an abnormal phosphate concentration is therefore as follows:
[Atot] (in meq/l) = (1.84 ± 0.42) × [total protein] (in g/dl) + 0.59 [phosphate] (in mg/dl), where [phosphate] is
phosphate concentration. The error estimate for
[Atot] was attributed
entirely to total protein, because the error in estimating
[Atot] from phosphate
was comparatively much smaller.
Nonlinear regression using Stewart's strong ion model
(Eq. 8) produced values for
[Atot] and
Ka in three
plasma samples similar to those obtained with the simplified strong ion
model, an unrealistic value for
Ka (6.4 × 10
9 eq/l) in one plasma
sample, and did not produce a mathematical solution in the two
remaining plasma samples (Table 5).
Nonlinear regression using the simplified strong ion model
(Eq. 15) produced a mean estimate
for [Atot] of purified
horse serum protein (2.05 × [total protein], in g/dl)
that was within the 95% confidence interval for the value calculated
above for a non-phosphate-containing solution: (1.84 ± 0.46) × [total protein] (in g/dl) (Table
6). The estimated values for
[Atot] {(1.4 ± 0.6) × [globulin] (in g/dl)}, where
[globulin] is globulin concentration, and
Ka [(3.4 ± 1.9) × 10
7
eq/l] of horse globulin were not significantly different from the
values obtained for horse plasma (Table 6). The calculated estimate for
[Atot] (1.84 × [total protein], in g/dl) of a solution containing purified
horse albumin ([Atot] = 2.25 × [albumin], in g/dl), where
[albumin] is albumin concentration, and horse globulin
([Atot] = 1.4 × [globulin], in g/dl) with a normal albumin-to-globulin ratio was within the 95% confidence interval for the value obtained for a non-phosphate-containing plasma protein solution.
|
Table 6.
Calculation of [Atot] and Ka for equine
albumin, globulin, and serum protein using published values for
PCO2, [SID+], pH, ionic
strength, temperature, pK 1, and
SCO2
|
| Protein |
n |
pH Range |
R2
|
[Atot], meq/l |
Ka,
10 7 eq/l |
Ref. |
|
| Albumin |
5 |
6.67-7.37
|
0.999 |
(2.2 ± 1.0) × [Alb]
|
2.3 ± 1.5 |
48, Table I |
| Albumin |
6
|
6.81-7.52 |
0.998 |
(2.3 ± 1.1) × [Alb]
|
2.3 ± 2.3 |
48, Table II |
| Globulin |
5
|
6.66-7.38 |
0.999 |
(1.4 ± 0.6) × [Glob]
|
3.4 ± 1.9 |
48, Table IV |
| Serum protein |
4
|
7.07-7.74 |
1.000 |
(2.0 ± 0.9) × [TP]
|
2.0 ± 0.6 |
47, Table V |
| Serum protein |
4
|
7.16-7.73 |
1.000 |
(2.1 ± 1.3) × [TP]
|
2.0 ± 0.8 |
47, Table VI |
|
|
Values for [Atot] and Ka were
determined using nonlinear regression and are expressed as mean
estimate ± SE of estimate; n, no. of samples. [Alb],
albumin concentration (in g/dl); [Glob], globulin concentration (in
g/dl); [TP], total protein concentration (in g/dl);
SCO2, solubility of CO2 in
plasma.
|
|
Model validation.
Data from the published studies covered a physiological range of
PCO2 (36-54 Torr),
[SID+] (22.2-52.9
meq/l), and total protein concentration (4.6-7.3 g/dl). By use of
the values experimentally determined by the simplifed strong ion model
for horse plasma
([Atot] = 2.24 × [total protein], in g/dl;
Ka = 2.22 × 10
7 eq/l), an
excellent correlation between calculated pH and measured pH was
observed for all experimental studies (Table
7, Fig. 2). The
values (means ± SD) for the slope (1.11 ± 0.12) and intercept (
0.84 ± 0.88) did not differ significantly from the line of
identity. The mean difference between the estimated and actual pH was
0.004 (range
0.054 to +0.049).
|
Table 7.
Summary of linear regression analysis of the relationship between
calculated and measured plasma pH
|
Model 1 [Atot] (meq/l) = 2.24 [TP] (g/dl)
Ka = 2.22 × 10 7 eq/l
|
Model 2 [Atot] (meq/l) = 20 Ka = 3.0 × 10 7 eq/l
|
Model 3 [Atot] (meq/l) = 2.4 [TP] (g/dl)
Ka = 3.0 × 10 7 eq/l
|
Ref.
|
|
pHc = 1.08 pHm 0.60 [0.93]
|
pHc = 1.01 pHm 0.15 [0.96]
|
pHc = 1.18 pHm 1.37 [0.93]
|
36, Figs. 1, 2, 3
|
pHc = 1.18 pHm 1.34 [0.78]
|
pHc = 1.96 pHm 7.26 [0.75]
|
pHc = 1.22 pHm 1.66 [0.74]
|
17, Table 2
|
pHc = 1.02 pHm 0.15 [0.94]
|
pHc = 1.58 pHm 4.42 [0.96]
|
pHc = 1.09 pHm 0.71 [0.95]
|
17, Table 3
|
| pHc = 0.93 pHm + 0.54 [0.96]
|
pHc = 1.44 pHm 3.40 [0.97]
|
pHc = 1.00 pHm 0.02 [0.96]
|
17, Table 4
|
pHc = 1.28 pHm 2.05 [0.86]
|
pHc = 1.68 pHm 5.15 [0.87]
|
pHc = 1.35 pHm 2.59 [0.86]
|
17, Table 5
|
pHc = 1.02 pHm 0.18 [0.95]
|
pHc = 1.03 pHm 0.37 [0.94]
|
pHc = 1.10 pHm 0.79 [0.95]
|
18, Table 1
|
pHc = 1.20 pHm 1.52 [0.92]
|
pHc = 1.52 pHm 4.02 [0.95]
|
pHc = 1.27 pHm 2.05 [0.92]
|
18, Table 2
|
pHc = 1.20 pHm 1.43 [0.96]
|
pHc = 1.23 pHm 1.82 [0.95]
|
pHc = 1.23 pHm 1.69 [0.95]
|
18, Table 3
|
| Mean ± SD
|
pHc = (1.11 ± 0.12)pHm (0.84 ± 0.88)
|
pHc = (1.43 ± 0.33)pHm (3.32 ± 2.44)
|
pHc = (1.18 ± 0.10)pHm (1.36 ± 0.73)
|
|
|
|
Plasma pH was calculated using [Atot] and
Ka values determined by simplified strong ion model
(model 1), Stewart's commonly used values (model
2), and values commonly used for human plasma (model
3). Plasma pH was calculated from published values (Refs. 17, 18,
and 36) for PCO2, [SID+], and
[TP]. Values in brackets are R2.
pHc, calculated pH; pHm, measured pH.
|
|
Fig. 2.
Scatterplot of relationship between calculated plasma
pH (calculated from reported values for
PCO2,
[SID+], and total
protein concentration) and measured plasma pH for horses (data from
Refs. 17, 18, and 36).
, Calculated pH values using values obtained
for [Atot] and
effective dissociation constant for plasma weak acids
(Ka) of horse
plasma obtained by simplified strong ion model;
, calculated pH
values using Stewart's commonly assumed values for
[Atot] and
Ka;
,
calculated pH values using commonly assumed
[Atot] and
Ka values for
human plasma. Solid line, line of identity; dashed lines, mean linear
regression lines for pH calculated using values assumed by Stewart or
for human plasma. TP, total protein.
[View Larger Version of this Image (27K GIF file)]
By use of the commonly accepted human plasma values for
[Atot] (2.4 × [total protein], in g/dl) and
Ka (3.0 × 10
7 eq/l), the
values (means ± SD) for the slope (1.18 ± 0.10) and intercept
(
1.36 ± 0.73) differed significantly
(P < 0.05) from the line of identity
(Table 7, Fig. 2). The mean difference between the estimated and actual
pH was
0.027 (range
0.084 to 0.000).
By use of a fixed value for
[Atot] (20.0 meq/l)
and the most commonly used value for
Ka (3.0 × 10
7 eq/l), the values
(means ± SD) for the slope (1.43 ± 0.33) and intercept
(
3.32 ± 2.44) also differed significantly from the line of
identity (Table 7, Fig. 2). The mean difference between the estimated
and actual pH was
0.135 (range
0.242 to
0.054).
DISCUSSION
The simplified strong ion model provides a quantitative mechanistic
acid-base model that explains many of the anomalies of the
Henderson-Hasselbalch equation. The model explains why the apparent
value for pK
1 in
plasma is dependent on pH, protein concentration, and
Na+ concentration and provides a
mechanistic explanation for the temperature dependence of plasma pH.
The simplified strong ion model provides a practical method for
experimentally determining [Atot] and
Ka that produces
values for horse plasma that are significantly different from those
most commonly used for human plasma. Finally, the model simplifies to
the Henderson-Hasselbalch equation when applied to aqueous nonprotein
solutions, thereby providing an acid-base model that unites the
Henderson-Hasselbalch equation and strong ion model.
Explanation for anomalies in the Henderson-Hasselbalch equation.
Rearrangement of Eq. 16 provides the
following expression
|
(19)
|
which
should be compared with Eq. 3 from the
Henderson-Hasselbalch equation. The simplified strong ion model
predicts that, over a physiological range of plasma pH at constant
temperature and ionic strength, the in vitro log
PCO2-pH equilibration curve will be
linear, because
[SID+],
SCO2, and pK
1
are constant and
Ka[Atot]/(Ka + 10
pH) is approximately
constant. In alkalotic plasma solutions,
Ka[Atot]/(Ka + 10
pH) approaches
[Atot], inasmuch as
(Ka + 10
pH)
Ka, because
Ka (2.22 × 10
7) > 10
pH. In markedly acidic
plasma solutions,
Ka[Atot]/(Ka + 10
pH) and, therefore,
the intercept value of the log
PCO2-pH relationship becomes pH
dependent, because 10
pH > Ka. The simplified strong ion
model therefore explains the nonlinearity of the log
PCO2-pH relationship in markedly acidic plasma.
As discussed previously, the Henderson-Hasselbalch equation fails to
explain why the log PCO2-pH
relationship is displaced by changes in protein,
Na+, and
Cl
concentration (2, 39)
(Fig. 1). The simplified strong ion model, through Eq. 19, predicts that, in solutions with increased protein
concentration (increased
[Atot]),
Ka[Atot]/(Ka + 10
pH) is increased,
thereby displacing the log PCO2-pH
curve to the left (Fig. 1). Addition of
Na+ increases the
[SID+], thereby
shifting the curve to the right (Fig. 1), whereas addition of
Cl
decreases the
[SID+], thereby
shifting the curve to the left (Fig. 1).
The simplified strong ion model also explains why the apparent
pK
1 in plasma is
dependent on pH, protein concentration, and
Na+ concentration. Values for the
apparent pK
1 in plasma are usually obtained by titrating a plasma sample with a known
amount of hydrochloric acid, thereby changing
[SID+]. This technique
assumes that plasma protein dissociation (the ratio of
[A
] to
[HA]) remains constant, regardless of the
PCO2 value (39) and that the known
[SID+] is equal to
and opposite from
[HCO
3]. The simplified
strong ion model suggests that the
[A
]-to-[HA]
ratio does not remain constant during in vitro
CO2 equilibration, inasmuch as
[Atot] and
[SID+] will remain
constant with changes in PCO2, but
pH, [A
], and
[HA] will vary, inasmuch as they are dependent variables. The apparent dependence of plasma
pK
1 on pH, when pK
1 is determined
by acid titration, therefore, results from the dependence of
[A
] on
PCO2 and
[SID+]. A similar
explanation can be offered for the effect of plasma protein and
Na+ concentration on the apparent
pK
1, inasmuch as protein concentration is the predominant determinant of
[Atot] and
Na+ concentration determines
[SID+]. Changes in
[Atot] or
[SID+] alter
[A
] and,
therefore, the ratio of
[A
] to
[HA]. The explanations above suggest that
pK
1, when used in
Stewart's strong ion model or the simplified strong ion model, should
be corrected only for temperature and ionic strength.
The simplified strong ion model predicts that
pK
1, determined by
acid titration, will not be influenced by pH in aqueous nonplasma
solutions, inasmuch as Eqs. 15 and 16 simplify to the
Henderson-Hasselbalch equation in nonplasma solutions (where [Atot] = 0). Studies
demonstrating a pH dependence of apparent pK
1 in serum, plasma, and
cerebrospinal fluid (1, 27, 34, 38), which contain various
concentrations of nonvolatile buffers
([Atot] > 0) but no
pH dependence in aqueous nonplasma solutions
([Atot] = 0) (1, 19,
27), support this prediction. Finally, the curvilinear nature of the in
vivo log PCO2-pH relationship (Fig.
1) results from changes in
[SID+] reflected by
alterations in plasma Na+,
K+, and
Cl
concentrations (6, 10),
inasmuch as acid-base status is regulated to ensure a constant protein
charge state (7).
Temperature dependence of plasma pH.
Equation 14 indicates that plasma pH
varies directly with plasma
pKa. It therefore
follows that
pH/
T will approximate
pKa/
T, where T is temperature. This is consistent with the alphastat hypothesis, because the
pH/
T of mammalian plasma (
0.015 to
0.020 unit/°C) is similar to the
pKa/
T of
imidazole (
0.016 unit/°C) (32). The simplified strong ion
model therefore provides a direct explanation for the temperature
dependence of plasma pH, in that plasma pH varies with temperature,
primarily because the value for
Ka varies with
temperature, and plasma pH is dependent on
Ka.
Temperature-induced changes in
K
1 and
SCO2 play a
much smaller role in the temperature-induced changes in pH. The effect
of temperature should not be neglected in studies utilizing Stewart's
strong ion model or the simplified strong ion model, inasmuch as an
increase in temperature of 4°C (a common occurrence during
strenuous exercise) will decrease plasma pH by ~0.06 unit, primarily
through temperature-induced changes in Ka.
The 95% confidence interval for the effective
Ka of horse
plasma at 37°C (2.22 ± 0.32 × 10
7 eq/l) includes the
value predicted for imidazole at 37°C (1.90 × 10
7 eq/l) on the basis of a
pKa of 6.95 for
imidazole at 25°C, a heat of enthalpy of 7,700 cal/mol (32), and
correction of this value for temperature by the van't Hoff equation.
The close agreement between the
Ka values for
horse plasma and imidazole is consistent with Reeve's hypothesis that
plasma nonvolatile buffers can be modeled as a single imidazole group
over the physiological range of pH (32).
Experimental determination of
[Atot] and
Ka.
The simplified strong ion model provides a practical in vitro method
for experimentally determining
[Atot] and
Ka. Of interest is the finding that the experimentally determined values for
[Atot] (15.0 ± 3.1 meq/l) and Ka
(2.22 ± 0.32 × 10
7 eq/l) of horse plasma
were significantly different from the values most commonly used for
human plasma ([Atot] = 20 meq/l, Ka = 3.0 × 10
7 eq/l) (45,
46). Figure 2 demonstrates that the experimentally determined values
for [Atot] and
Ka more
accurately predict pH for horse plasma than values derived from human
plasma. This emphasizes the point that species-specific values for
[Atot] and
Ka should be
experimentally determined when Stewart's strong ion model or the
simplified strong ion model is used to describe acid-base equilibria.
The nonlinear regression technique used in this study to estimate
[Atot] and
Ka was
complicated by the presence of multicollinearity. The correlation
between regression parameter estimates for
[Atot] and
Ka exceeded 0.95 for all analyses, indicating severe multicollinearity (16). The
presence of large standard errors for the parameter estimates, despite
excellent goodness of fit values
(R2
0.998)
(Table 6), and occasional unreasonable parameter estimates or inability
to provide a parameter estimate (Table 5) are also suggestive of
multicollinearity. Structural multicollinearity is inherent in the
simplified strong ion and Stewart's strong ion approaches because of
the mathematical relationship between [Atot] and
Ka demonstrated
in Eq. 10. Additional structural
multicollinearity exists in Stewart's strong ion approach because of
the mathematical relationship between
[OH
] and
[H+]
(Eq. 17), between
[CO2
3] and
[HCO
3] (Eq. 18), and between
[CO2
3] and
[H+]
(Eq. 18). Recommended methods for
analyzing data containing multicollinearities include using ridge
regression techniques (such as Marquardt's approach used in this
study), reformulating the mathematical equation (the equations used
demonstrated the least multicollinearity), and eliminating parameters
from the regression model (16, 37). On the basis of the derivation in
APPENDIX C and the results in Table 4,
it appeared that two parameters
([OH
] and
[CO2
3]) could be
removed from Stewart's strong ion model. When this was done
(equivalent to reducing the strong ion model to the simplified strong
ion model), realistic estimates for
[Atot] and
Ka were obtained
for six of six tonometered horse plasma samples compared with three of
six samples when Stewart's approach was used (Table 5). In other
words, experimental determination of
[Atot] and
Ka is facilitated
by use of the simplified strong ion model.
Independent determinants of plasma pH.
Equation 15 indicates that six factors
(PCO2,
[SID+],
[Atot],
Ka,
K
1, and
SCO2)
physicochemically determine plasma pH. Not all these factors exert an
independent effect on plasma pH, inasmuch as the apparent dissociation
constants Ka and
K
1 are dependent on
temperature and ionic strength,
SCO2 is
dependent on temperature, ionic strength, and protein concentration,
and [Atot] and
Ka are dependent
on the relative contributions of individual nonvolatile plasma buffers (such as albumin, globulin, and phosphate). The independent factors that determine plasma pH are therefore
PCO2,
[SID+], concentration
of individual nonvolatile plasma buffers (albumin, globulin, and
phosphate), ionic strength, and temperature. A change in any one of
these variables will produce a direct and predictable change in plasma
pH.
Limitations of the simplified strong ion model.
The major limitations of the simplified model are identical to those of
Stewart's strong ion model in that
1) an accurate value for
[SID+] can be
difficult to obtain, 2) values for
[Atot] and
Ka are pH
dependent when expressed in terms of milliequivalents per liter, 3) values for
[Atot] and
Ka depend on the
relative concentrations of the four nonvolatile plasma buffers
(imidazole,
-amino, H2PO
4, and citric acid), and 4) the
heterogeneous group of nonvolatile plasma buffers with an approximately
linear titration curve is being modeled as a single buffer with a
classic sigmoidal titration curve. Despite these limitations, the
simplified strong ion model can be used clinically, in that it predicts
plasma pH within 0.05 unit (with a mean prediction within 0.001 unit)
from measured values for PCO2,
[SID+], and total
protein concentration (Fig. 2, Table 7).
PCO2 can be measured accurately to
within 1 Torr, resulting in an error of 0.01 unit in the predicted pH.
[SID+] can be measured
within 3 meq/l when calculated from the
Na+,
K+,
Cl
, and
lactate
concentrations, the
error resulting from cumulative measurement errors and the presence of
unmeasured strong ions. This produces an error of 0.05 unit in the
predicted pH. [Atot]
can be measured within 10%, the error resulting from changes in the
albumin-to-globulin ratio or a marked increase in the phosphate
concentration. This produces an error in pH of 0.02 unit. The
simplified strong ion model should therefore produce a maximum error in
the predicted pH of ~0.08 unit, a value that exceeds the observed
maximum error (0.06 unit) when the model was applied to published data
(Table 7, Fig. 2). Other studies have shown that Stewart's strong ion model predicts plasma pH within a similar error margin (13, 30).
The pH dependence of
[Atot] and
Ka is
theoretically of some concern but is practically inconsequential. As
demonstrated in APPENDIX A,
[Atot] is pH dependent
when expressed in terms of milliequivalents per liter. The effect of
this pH dependence on
[Atot] (in meq/l) is
very small, however, inasmuch as the predominant determinant of
[Atot] (in meq/l) is
the net charge produced by fully dissociated groups on plasma proteins
(APPENDIX A, Table 3). A decrease in
plasma pH from 7.40 to 6.80 alters the calculated value of
[Atot] from 18.0 to
17.5 meq/l, a change of 2.2%. An increase in plasma pH from 7.40 to
7.70 alters the calculated value of
[Atot] from 18.0 to
18.5 meq/l, a change of 2.8%. As calculated above, these changes in
[Atot] will result in
an error in predicted pH of <0.01. For practical purposes,
[Atot] can therefore be considered constant over the physiological range of pH
(6.8-7.7). An explanation as to why plasma
Ka also varies
with pH is the functional categorization used in this study to
differentiate strong ions from buffer ions, namely, whether the
individual pKa falls within the range of pH ±1.5. For example, nuclear magnetic resonance examination of human serum albumin indicates that the pKa of individual
imidazole groups ranges from 5.2 to 7.9, with an overall mean of ~6.9
(5). An increase in pH from 7.4 to 7.7 causes imidazole residues with a
pKa between 5.9 and 6.2 to effectively lose their ability to function as a nonvolatile
buffer, potentially altering the apparent plasma
Ka. The resultant
effect on predicted pH is small, however, inasmuch as an increase in Ka from 2 × 10
7 to 3 × 10
7 eq/l changes plasma pH
by <0.01. The dependence of
[Atot] and Ka on plasma pH
does not invalidate the simplified strong ion model and Stewart's
strong ion model; instead it limits the pH range to which both models
can be accurately applied. Validation of the simplified strong ion
model (Table 7, Fig. 2) indicates that the experimentally determined
values for [Atot] and
Ka are accurate
in the horse for pH 7.20-7.60. It is unknown whether these values
remain accurate outside this pH range.
Concern has been raised over the effect of changes in the relative
concentrations of albumin, globulin, and phosphate on
[Atot] and
Ka (11), the
effect of citrate being ignored because of its relatively low plasma
concentration. Removal of phosphate from plasma will decrease
[Atot] by ~20% but
not change Ka,
inasmuch as phosphate normally contributes 2.7 meq/l to
[Atot]
(APPENDIX A) and has a
Ka (2 × 10
7) similar to that of
imidazole and plasma. A fivefold increase in plasma phosphate
concentration will also not change plasma Ka but will
increase [Atot] by
10.8 meq/l. This will result in a large increase in
[Atot] and, therefore,
a decrease in plasma pH. The effect of the globulin concentration on
[Atot] and
Ka requires
consideration, inasmuch as the estimated values for
[Atot] and
Ka of horse
globulin may differ from those of plasma, although a significant
difference was not observed in this study. This suggests that an
altered albumin-to-globulin ratio could alter the effective values for
[Atot] and
Ka in the horse.
This is not surprising, in that the amino acid composition of globulin
(particularly the composition of dissociable imidazole and
-amino
groups) probably differs from that of albumin. Because of the
concordance between estimates for
[Atot] obtained for
normal horse plasma and solutions of purified horse serum protein, the
following equation is suggested to estimate
[Atot] for horse
plasma with abnormal concentrations of albumin, globulin, or phosphate
|
(20)
|
The titration curve of plasma protein over the physiological range of
pH (6.6-7.8) is approximately linear (40, 47-51). This result
has been attributed to the titration of dissociable imidazole and
-amino groups that possess different intrinsic pKa values (7).
The simplified strong ion model (and Stewart's strong ion model)
reduces the heterogeneous group of dissociable plasma buffers to a
single imidazole group with a clearly identifiable pKa. This
modeling assumption is consistent with the alphastat theory for
acid-base regulation (32); however, the model appears to be
inconsistent with experimental observation, in that over a wide range
of pH this modeling assumption would produce a sigmoidal, rather than a
linear, relationship between net protein charge and pH (7) (Fig.
3). However, close examination of the
titration curves for albumin, globulin, and serum protein modeled as
homogeneous buffers reveals that the net protein charge-pH relationship
can be well approximated by a straight line over the pH range used in
titration studies (Fig. 3). Moreover, the validation study indicates
that the simplification is accurate for horse plasma over a
physiological pH range of 7.2-7.6. It remains to be determined whether this simplification remains valid over a wider range of pH.
Fig. 3.
Titration curves for horse albumin, globulin, and
total protein modeled as a single imidazole group with a specific
pKa (values determined by nonlinear regression using simplified strong ion model
from values in Refs. 50 and 51). Superimposed on each modeled titration
curve are individual data points (
) for net protein charge-pH
relationship determined in Refs. 50 and 51. Vertical lines represent
range of pH used for titration.
A
, conjugate base; HA, weak
acid.
[View Larger Version of this Image (21K GIF file)]
Generalizability of simplified strong ion model.
The approach used to develop the simplified strong ion model can be
applied to any biological fluid consisting of strong ions, volatile
buffer ions, and nonvolatile buffer ions, provided that the effects of
complex ion interactions, oxidation-reduction reactions, and
precipitation reactions in the fluid are quantitatively unimportant. If
these criteria are not met, the simplified strong ion model should not
be applied, because one of the model's assumptions (all quantitatively
important chemical reactions are those of simple ions in solution) has
been violated. The simplified strong ion model can therefore be adapted
to describe acid-base equilibria in peritoneal, pleural, pericardial,
interstitial, synovial, and cerebrospinal fluid, as well as in
erythrocytes. The model should not be applied to urine, because
precipitation reactions and complex ion interactions occur in this
medium. Similar difficulties may occur when the model is applied to the
intracellular environment.
FOOTNOTES
Address for reprint requests: P. D. Constable, Dept. of Veterinary
Clinical Medicine, College of Veterinary Medicine, University of
Illinois at Urbana-Champaign, 1008 West Hazelwood Dr., Urbana, IL
61801.
Received 19 December 1994; accepted in final form 14 February
1997.
APPENDIX A
An estimate for the value of
[Atot] in
milliequivalents per liter can be obtained by determining the molar
concentration and attributing a valence to [HA] and
[A
] for the
four nonvolatile plasma buffers and then summing the resultant values
for [HA] and
[A
] when
expressed in milliequivalents per liter. Accurate data are available
for human and bovine albumin (47, 48), and the following estimate for
[Atot] is calculated
for a solution resembling human plasma that has no globulin.
For imidazole at pH 7.40, the ratio of [HA] to
[A
] equals 0.2, inasmuch as Ka = 2 × 10
7 eq/l. For
human albumin the value for [HA] in milliequivalents per
liter can be calculated as
|
(A1)
|
Human albumin contains 16 dissociable imidazole groups and 4 dissociable
-amino groups (47),
with the fully dissociated groups producing a net valence of
26
eq (Table 3). Because the valence for
HAimidazole = +1, the following
equations can be derived for a solution containing 4.1 g/dl albumin
(mol wt of human albumin = 69,000)
|
(A2)
|
|
(A3)
|
For
-amino groups at pH 7.40, the ratio of [HA] to
[A
] equals 2.0, inasmuch as Ka = 2 × 10
8 eq/l. Because
the valence for
[HA]
-amino = 0, the
following equations can be derived for a solution containing 4.1 g/dl
albumin
|
(A4)
|
|
(A5)
|
For phosphate at pH 7.40, the ratio of
[H2PO
4] to
[HPO2
4] (where
[H2PO
4] and
[HPO2
4] are concentrations
of H2PO
4 and
HPO2
4) equals 0.2, inasmuch as
Ka = 2 × 10
7 eq/l. For human plasma
with a phosphate concentration of 4 mg/dl (1.29 mmol/l), the following
equations can be calculated
|
(A6)
|
|
(A7)
|
For citric acid at pH 7.40, the ratio of
[R · COOH] to
[R · COO
]
equals 1.2, inasmuch as
Ka = 7.9 × 10
7 eq/l. For human plasma
with a citrate concentration of 0.6 mmol/l, the following equations can
be calculated
|
(A8)
|
|
(A9)
|
The value for [Atot]
in milliequivalents per liter for an electrolyte solution containing
human albumin can now be estimated
|
(A10)
|
where [HA]i
and
[A
]i
are the ith value for [HA] and
[A
].
The value derived for
[Atot] in
milliequivalents per liter is approximate, inasmuch as the number of
dissociated groups in albumin is approximate (47, 48). A similar
approach for a solution resembling bovine plasma (Table 3) (48), which
has no globulin (assuming [albumin] = 3.2 g/dl; mol
wt of albumin = 65,000; [phosphate] = 1.29 mmol/l)
produces an estimate for [Atot] of 12.8 meq/l,
which differs from that obtained for human albumin solution. This
suggests that the value for
[Atot] will vary among
species.
APPENDIX B
Equation 12 can be rearranged to provide
|
(B1)
|
Which
can be expanded
to
|
(B2)
|
Substituting for
[HCO
3] from the overall
equilibrium reaction for the Henderson-Hasselbalch equation
(Eq. 1), such that
[HCO
3] = K
1SCO2PCO2/aH+ provides
|
(B3)
|
Multiplying both sides of Eq. B3 by
[H+] (i.e.,
aH+) provides
|
(B4)
|
The general solution of the quadratic equation
ax2 + bx + c = 0 is
x = (
b ±
)/2a. The solution for Eq. B4 is therefore
|
(B5)
|
Expansion
and rearrangement provides
|
(B6)
|
which
is equivalent to
|
(B7)
|
which can be further simplified to
|
(B8)
|
Taking
the logarithm of the reciprocal of both sides of Eq. B8 produces only one real solution
|
(B9)
|
APPENDIX C
Stewart developed the following equation relating
[H+] to 3 independent
variables (PCO2,
[SID+],
[Atot]) and 4 "constants"
(Ka,
K
w,
K3, and Kc), where
Kc = K
1 × SCO2
|
(C1)
|
Simplification of Eq. C1 for mammalian
plasma at 37°C requires recognition that the equation can be
rewritten as
|
(C2)
|
and
that using appropriate units, the approximate values of
[SID+] and
[Atot] are 4 × 10
2 and 2 × 10
2 eq/l, respectively,
PCO2 is ~4 × 101 Torr,
[H+] is 40 × 10
9 eq/l,
Ka is on the
order of 2 × 10
7
eq/l, Kc and
K3 are ~2.5 × 10
11
eq · l
1 · Torr
1
and 6.0 × 10
11 eq/l,
respectively, and
K
w is 4.4 × 10
14
eq2/l2.
On this basis
Substituting
the above into Eq. C2
provides
|
(C3)
|
Substituting for PCO2 from
Eq. 1 provides
|
(C4)
|
which simplifies to
|
(C5)
|
Simplification of Eq. C5
for physiological plasma requires recognition that Eq. C5 can be rewritten as
|
(C6)
|
The
approximate values of each term in Eq. C6 can now be calculated, given that
[HCO
3] = 2.5 × 10
2 eq/l,
[CO2
3] = 3.8 × 10
5 eq/l, and
[OH
] = 1.1 × 10
6 eq/l
(calculated from above)
The
[H+]3
term can therefore be ignored, and Eq. C6 can be simplified to
|
(C7)
|
The general solution of the quadratic equation
ax2 + bx + c = 0 is
x = (
b ±
)/2a. The solution for Eq. C7 is therefore
|
(C8)
|
which is equivalent
to
|
(C9)
|
This can be simplified to
|
(C10)
|
on the basis that
and
that
Equation
C10 can be expressed as
|
(C11)
|
The
only real solution of Eq. C11 is
|
(C12)
|
which
simplifies to
|
(C13)
|
Taking
the logarithm of the reciprocal of both sides of Eq. C13 produces
|
(C14)
|
which
is similar to Eq. 14 developed from
the simplified strong ion model, assuming that Stewart's parameter
[H+] approximates the
H+ activity.
REFERENCES
| 1.
|
Alexander, S. C.,
R. Gelfand,
and
C. J. Lambertson.
The pK of carbonic acid in cerebrospinal fluid.
J. Biol. Chem.
236:
592-596,
1961[Free Full Text].
|
| 2.
|
Astrup, P.
A simple electrometric technique for the determination of carbon dioxide tension in blood and plasma, total content of carbon dioxide in plasma, and bicarbonate content in separated plasma at a fixed carbon dioxide tension (40 mmHg).
Scand. J. Clin. Lab. Invest.
8:
33-43,
1956[Medline].
|
| 3.
|
Austin, W. H.,
E. Lacombe,
P. W. Rand,
and
M. Chatterjee.
Solubility of carbon dioxide in serum from 15 to 38°C.
J. Appl. Physiol.
18:
301-304,
1963[Abstract/Free Full Text].
|
| 4.
|
Bjerrum, N.
Die Dissoziation der starken Elektrolyten.
Z. Electrochem.
24:
321-328,
1918.
|
| 5.
|
Bos, O. J. M.,
J. F. A. Labro,
M. J. E. Fischer,
J. Wilting,
and
L. H. M. Janssen.
The molecular mechanism of the neutral-to-base transition of human serum albumin.
J. Biol. Chem.
264:
953-959,
1989[Abstract/Free Full Text].
|
| 6.
|
Brackett, N. C.,
J. J. Cohen,
and
W. B. Schwartz.
Carbon dioxide titration curve of normal man.
N. Engl. J. Med.
272:
6-12,
1965.
|
| 7.
|
Cameron, J. N.
Acid-base homeostasis: past and present perspectives.
Physiol. Zool.
62:
845-865,
1989.
|
| 8.
|
Cullen, G. E.,
H. R. Keeler,
and
H. W. Robinson.
The pK of the Henderson-Hasselbalch equation for hydrion concentration of blood and serum.
J. Biol. Chem.
66:
301-322,
1925[Free Full Text].
|
| 9.
|
Edsall, J. T.,
and
J. Wyman.
Biophysical Chemistry. New York: Academic, 1958, vol. 1, p. 406-662.
|
| 10.
|
Elkinton, J. R.,
R. B. Singer,
E. S. Barker,
and
J. F. Clark.
Effects in man of acute experimental respiratory alkalosis and acidosis on ionic transfers in the total body fluids.
J. Clin. Invest.
34:
1671-1690,
1955.
|
| 11.
|
Fencl, V.,
and
D. E. Leith.
Stewart's quantitative acid-base chemistry: applications in biology and medicine.
Respir. Physiol.
91:
1-16,
1993[Medline].
|
| 12.
|
Figge, J.,
T. Mydosh,
and
V. Fencl.
Serum proteins and acid-base equilibria: a follow-up.
J. Lab. Clin. Med.
120:
713-719,
1992[Medline].
|
| 13.
|
Figge, J.,
T. H. Rossing,
and
V. Fencl.
The role of serum proteins in acid-base equilibria.
J. Lab. Clin. Med.
117:
453-467,
1991[Medline].
|
| 14.
|
Forster, H. V.,
C. L. Murphy,
A. G. Brice,
L. G. Pan,
and
T. F. Lowry.
Plasma [H+] regulation and whole blood [CO2] in exercising ponies.
J. Appl. Physiol.
68:
309-315,
1990[Abstract/Free Full Text].
|
| 15.
|
Frischmeyer, K. J.,
and
P. F. Moon.
Evaluation of quantitative acid-base balance and determination of unidentified anions in swine.
Am. J. Vet. Res.
55:
1153-1157,
1994[Medline].
|
| 16.
|
Glantz, S. A.,
and
B. K. Slinker.
Primer of Applied Regression and Analysis of Variance. New York: McGraw-Hill, 1990, p. 1-777.
|
| 17.
|
Gossett, K. A.,
D. D. French,
B. Cleghorn,
and
G. E. Church.
Effect of acute acidemia on blood biochemical variables in healthy ponies.
Am. J. Vet. Res.
51:
1375-1379,
1990[Medline].
|
| 18.
|
Gossett, K. A.,
D. D. French,
B. Cleghorn,
and
G. E. Church.
Blood biochemical response to sodium bicarbonate infusion during sublethal endotoxemia in ponies.
Am. J. Vet. Res.
51:
1370-1374,
1990[Medline].
|
| 19.
|
Harned, H. S.,
and
F. T. Bonner.
The first ionization of carbonic acid in aqueous solutions of sodium chloride.
J. Am. Chem. Soc.
67:
1026-1031,
1945.
|
| 20.
|
Hasselbalch, K. A.
Die Berechnung der Wasserstoffzahl des blutes auf der freien und gebundenen Kohlensaure desselben, und die Sauerstoffbindung des Blutes als Funktion der Wasserstoffzahl.
Biochem. Z.
78:
112-144,
1916.
|
| 21.
|
Hastings, A. B.,
and
J. Sendroy.
The effect of variation in ionic strength on the apparent first and second dissociation constants of carbonic acid.
J. Biol. Chem.
66:
445-455,
1925.
|
| 22.
|
Heisler, N.
Acid-Base Regulation in Animals. New York: Elsevier, 1986.
|
| 23.
|
Henderson, L. J.
The theory of neutrality regulation in the animal organism.
Am. J. Physiol.
21:
427-428,
1908.
|
| 24.
|
Johnson, R. E.,
H. T. Edwards,
D. B. Dill,
and
J. W. Wilson.
Blood as a biochemical system. XIII. The distribution of lactate.
J. Biol. Chem.
157:
461-473,
1945[Free Full Text].
|
| 25.
|
Jones, N. L.
Blood Gases and Acid-Base Physiology. New York: Thieme, 1987, p. 83-185.
|
| 26.
|
Kowalchuk, J. M.,
G. J. F. Heigenhauser,
M. I. Lindinger,
J. R. Sutton,
and
N. L. Jones.
Factors influencing hydrogen ion concentration in muscle after intense exercise.
J. Appl. Physiol.
65:
2080-2089,
1988[Abstract/Free Full Text].
|
| 27.
|
Maas, A. H. J.,
A. N. P. van Heijst,
and
B. F. Visser.
The determination of the true equilibrium constant (pK1g) and the practical equilibrium coefficient (pK1g) for the first ionization of carbonic acid in solutions of sodium bicarbonate, cerebrospinal fluid, plasma, and serum at 25 and 38°.
Clin. Chim. Acta
33:
325-343,
1971[Medline].
|
| 28.
|
Mecher, C.,
E. C. Rackow,
M. E. Astiz,
and
M. H. Weil.
Unaccounted for anion in metabolic acidosis during severe sepsis in humans.
Crit. Care Med.
19:
705-711,
1991[Medline].
|
| 29.
|
Mitchell, R. A.,
D. A. Herbert,
and
C. T. Carman.
Acid-base constants and temperature coefficients for cerebrospinal fluid.
Am. J. Physiol.
20:
27-30,
1965.
|
| 30.
|
Pieschl, R. L.,
P. W. Toll,
D. E. Leith,
L. J. Peterson,
and
M. R. Fedde.
Acid-base changes in the running greyhound: contributing variables.
J. Appl. Physiol.
73:
2297-2304,
1992[Abstract/Free Full Text].
|
| 31.
|
Putnam, R. W.,
and
A. Roos.
Which value for the first dissociation constant of carbonic acid should be used in biological work?
Am. J. Physiol.
260 (Cell Physiol. 29):
C1113-C1116,
1991[Abstract/Free Full Text].
|
| 32.
|
Reeves, R. B.
An imadazole alphastat hypothesis for vertebrate acid-base regulation: tissue carbon dioxide content and body temperature in bullfrogs.
Respir. Physiol.
14:
219-236,
1972[Medline].
|
| 33.
|
Reeves, R. B.
Error proved and corrected: net anionic charge on serum albumin.
J. Lab. Clin. Med.
117:
437,
1991[Medline].
|
| 34.
|
Rispens, P.,
C. W. Dellebarre,
D. Eleveld,
W. Helder,
and
W. G Zijlstra.
The apparent first dissociation constant of carbonic acid in plasma between 16 and 42.5°.
Clin. Chim. Acta
22:
627-637,
1971.
|
| 35.
|
Rossing, T. H.,
N. Maffeo,
and
V. Fencl.
Acid-base effects of altering plasma protein concentration in human blood in vitro.
J. Appl. Physiol.
61:
2260-2265,
1986[Abstract/Free Full Text].
|
| 36.
|
Rumbaugh, G. E.,
G. P. Carlson,
and
D. Harrold.
Clinicopathologic effects of rapid infusion of 5% sodium bicarbonate in 5% dextrose in the horse.
J. Am. Vet. Med. Assoc.
178:
267-271,
1981[Medline].
|
| 37.
| SAS Institute. SAS/STAT User's Guide, release 6.03. Cary, NC: SAS, 1988, p. 675-712.
|
| 38.
|
Severinghaus, J. W.,
M. Stupfel,
and
A. F. Bradley.
Variations of serum carbonic acid pK with pH and temperature.
J. Appl. Physiol.
9:
197-200,
1956[Abstract/Free Full Text].
|
| 39.
|
Siggaard-Andersen, O.
The first dissociation exponent of carbonic acid as a function of pH.
Scand. J. Clin. Lab. Invest.
14:
587-597,
1962[Medline].
|
| 40.
|
Siggaard-Andersen, O.
The Acid-Base Status of the Blood. Copenhagen: Munksgaard, 1963.
|
| 41.
|
Singer, R. B.,
and
A. B. Hastings.
An improved clinical method for the estimation of disturbances of the acid-base balance of human blood.
Medicine
27:
223-242,
1948[Medline].
|
| 42.
|
Smith, R. B.,
and
A. E. Martell.
Critical Stability Constants. New York: Plenum, 1989, vol. 6, suppl. 2.
|
| 43.
|
Stainsby, W. N.,
and
P. D. Eitzman.
Role of CO2, O2, and acid in arteriovenous [H+] difference during muscle contractions.
J. Appl. Physiol.
65:
1803-1810,
1988[Abstract/Free Full Text].
|
| 44.
|
Stewart, P. A.
Independent and dependent variables of acid-base control.
Respir. Physiol.
33:
9-26,
1978[Medline].
|
| 45.
|
Stewart, P. A.
How to Understand Acid-Base. New York: Elsevier, 1981.
|
| 46.
|
Stewart, P. A.
Modern quantitative acid-base chemistry.
Can. J. Physiol. Pharmacol.
61:
1444-1461,
1983[Medline].
|
| 47.
|
Tanford, C.
Preparation and properties of serum and plasma proteins. XXIII. Hydrogen ion equilibria in native and modified human serum albumins.
J. Am. Chem. Soc.
72:
441-451,
1950.
|
| 48.
|
Tanford, C.,
S. A. Swanson,
and
W. S. Shore.
Hydrogen ion equilibria in bovine serum albumin.
J. Am. Chem. Soc.
77:
6414-6421,
1955.
|
| 49.
|
Van Leeuwen, A. M.
Net cation equivalency (base binding power) of the plasma proteins.
Acta Med. Scand. Suppl.
422:
1-212,
1964.
|
| 50.
|
Van Slyke, D. D.,
A. G. Hastings,
A. Hiller,
and
J. Sendroy.
Studies of gas and electrolyte equilibria in blood. XIV. The amounts of alkali bound by serum albumin and globulin.
J. Biol. Chem.
79:
769-780,
1928[Free Full Text].
|
| 51.
|
Van Slyke, D. D.,
H. Wu,
and
F. C. McLean.
Studies of gas and electrolyte equilibria in the blood. Factors controlling the electrolyte and water distribution in the blood.
J. Biol. Chem.
55:
765-849,
1923.
|
| 52.
|
Warburg, E. J.
Studies on carbonic acid compounds and hydrogen ion activities in blood and salt solutions.
Biochem. J.
16:
153-340,
1922.
|
| 53.
|
Weinstein, Y.,
A. Magazanik,
A. Grodjinovsky,
O. Inbar,
R. A. Dlin,
and
P. A. Stewart.
Reexamination of Stewart's quantitative analysis of acid-base status.
Med. Sci. Sports Exer.
23:
1270-1275,
1991[Medline].
|
0161-7567/97 $5.00
Copyright © 1997 the American Physiological Society